NASDAQ: COAG Hemab Therapeutics Holdings, Inc. 8-K

Hemab Therapeutics board member Laura Tadvalkar resigns effective immediately

Filed May 11, 2026 · Period ending May 8, 2026 · ~1 min read

1 material change detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade COAG commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 1, 2026 7:28 PM